80 FR 70820 - Eighth Annual Sentinel Initiative; Public Workshop; Request for Comments

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 80, Issue 220 (November 16, 2015)

The Food and Drug Administration (FDA) is announcing a public workshop entitled ``Eighth Annual Sentinel Initiative Public Workshop.'' Convened by the Center for Health Policy at the Brookings Institution and supported by a cooperative agreement with FDA, this 1- day workshop will bring the stakeholder community together to discuss a variety of topics on active medical product surveillance. Topics will include an update on the state of FDA's Sentinel Initiative, including an overview of the transition from the Mini-Sentinel pilot to the full Sentinel System, and key activities and uses of the Sentinel System accomplished in 2015. In addition, panelists will discuss the future of the Sentinel System and opportunities to expand its medical product surveillance capabilities. This workshop will also engage stakeholders to discuss current and emerging Sentinel projects.

[Federal Register Volume 80, Number 220 (Monday, November 16, 2015)]
[Notices]
[Pages 70820-70821]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-28851]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-3972]


Eighth Annual Sentinel Initiative; Public Workshop; Request for 
Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a public 
workshop entitled ``Eighth Annual Sentinel Initiative Public 
Workshop.'' Convened by the Center for Health Policy at the Brookings 
Institution and supported by a cooperative agreement with FDA, this 1-
day workshop will bring the stakeholder community together to discuss a 
variety of topics on active medical product surveillance. Topics will 
include an update on the state of FDA's Sentinel Initiative, including 
an overview of the transition from the Mini-Sentinel pilot to the full 
Sentinel System, and key activities and uses of the Sentinel System 
accomplished in 2015. In addition, panelists will discuss the future of 
the Sentinel System and opportunities to expand its medical product 
surveillance capabilities. This workshop will also engage stakeholders 
to discuss current and emerging Sentinel projects.

DATES: The public workshop will be held on February 3, 2016, from 9 
a.m. to 4 p.m., Eastern Standard Time (EST).
    Location: The public workshop will be held at the Renaissance 
Washington, DC Dupont Circle Hotel, 1143 New Hampshire Ave. NW., 
Washington, DC 20037. For additional travel and hotel information, 
please refer to http://www.eventbrite.com/e/sentinel-public-event-2016-tickets-19294863456. (FDA has verified the Web site addresses 
throughout this notice, but FDA is not responsible for subsequent 
changes to the Web sites after this document publishes in the Federal 
Register.)
    There will also be a live webcast for those unable to attend the 
meeting in person (see Streaming Webcast of the Public Workshop).

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to http://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper 
submissions): Division of Dockets Management (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of 
Dockets Management, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2015-N-3972 for ``Eighth Annual Sentinel Initiative; Public 
Workshop.'' Received comments will be placed in the docket and, except 
for those submitted as ``Confidential Submissions,'' publicly viewable 
at http://www.regulations.gov or at the Division of Dockets Management 
between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the

[[Page 70821]]

claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on http://www.regulations.gov. 
Submit both copies to the Division of Dockets Management. If you do not 
wish your name and contact information to be made publicly available, 
you can provide this information on the cover sheet and not in the body 
of your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Division of Dockets Management, 5630 Fishers 
Lane, Rm. 1061, Rockville, MD 20852.

FOR MORE INFORMATION CONTACT:  Carlos Bell, Center for Drug Evaluation 
and Research, Food and Drug Administration, 10903 New Hampshire Ave., 
Bldg. 22, Rm. 4343, Silver Spring, MD 20993-0002, 301-796-3714, FAX: 
301-796-9832, email: [email protected].
    Registration: To attend the public workshop, you must register 
before February 3, 2016, by visiting http://www.eventbrite.com/e/sentinel-public-event-2016-tickets-19294863456. You may also register 
for the live webcast by visiting this Web page. There will be no onsite 
registration. When registering, please provide the following 
information: Your name, title, company or organization (if applicable), 
postal address, telephone number, and email address. Those without 
Internet access should contact Carlos Bell to register (see FOR MORE 
INFORMATION CONTACT). There is no registration fee for the public 
workshop. However, registration will be on a first-come, first-served 
basis because seating is limited. Therefore, early registration is 
recommended. A 1-hour lunch break is scheduled, but food will not be 
provided. There are multiple restaurants within walking distance of the 
Renaissance Washington, DC Dupont Circle Hotel.
    If you need special accommodations due to a disability, please 
contact Joanna Klatzman at the Brookings Institution (phone: 813-586-
1201, email: [email protected]) at least 7 days in advance.
    Streaming Webcast of the Public Workshop: This public workshop will 
also be webcast (archived video footage will be available following the 
workshop). Persons interested in viewing the live webcast must register 
online by February 2, 2016, at 5 p.m. EST. Early registration is 
recommended because webcast connections are limited. Organizations are 
requested to register all participants but to view using one connection 
per location whenever possible. Webcast participants will be sent 
technical system requirements in advance of the event. Prior to joining 
the streaming webcast of the public workshop, it is recommended that 
you review these technical system requirements.
    Meeting Materials: All event materials will be available to 
registered attendees via email before the workshop at the Eventbrite 
Web site at http://www.eventbrite.com/e/sentinel-public-event-2016-tickets-19294863456.
    Transcripts: Please be advised that transcripts will not be 
available.

    Dated: November 9, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-28851 Filed 11-13-15; 8:45 am]
BILLING CODE 4164-01-P